Cardiac resynchronization in chronic heart failure

New England Journal of Medicine

Volumn 346, Issue 24, 2002, Pages 1845-1853

  Abraham, William T ^a   Fisher, Westby G ^a   Smith, Andrew L ^b   Delurgio, David B ^b   Leon, Angel R ^b   Loh, Evan ^c   Kocovic, Dusan Z ^c   Packer, Milton ^d   Clavell, Alfredo L ^e   Hayes, David L ^e   Ellestad, Myrvin ^f   Trupp, Robin J ^g   Underwood, Jackie ^b   Pickering, Faith ^c   Truex, Cindy ^e   McAtee, Peggy ^f   Messenger, John ^f  

^a UNIVERSITY OF KENTUCKY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d College of Physicians and Surgeons ^*

^e MAYO CLINIC   (United States)

^f LONG BEACH MEMORIAL MEDICAL CENTER   (United States)

^g UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ASYSTOLE; BRADYCARDIA; CARDIAC RESYNCHRONIZATION THERAPY; CELL SYNCHRONIZATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY SINUS; DEVICE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; HEART ATRIUM PACING; HEART EJECTION FRACTION; HEART FAILURE; HEART MUSCLE CONDUCTION DISTURBANCE; HEART VENTRICLE CONDUCTION; HOSPITALIZATION; HUMAN; HYPOTENSION; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; PERICARDIOCENTESIS; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TREADMILL EXERCISE; TREATMENT FAILURE; TREATMENT OUTCOME; WALKING;

AGED; CARDIAC PACING, ARTIFICIAL; DOUBLE-BLIND METHOD; EXERCISE TOLERANCE; FEMALE; HEART FAILURE, CONGESTIVE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; QUALITY OF LIFE; STROKE VOLUME; SURVIVAL ANALYSIS;

EID: 0037071808     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa013168     Document Type: Article

References (40)

1. How many people with heart failure are appropriate for biventricular resynchronization?
2. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation
3. Effects of abnormal activation on the time course of the left ventricular pressure pulse in dilated cardiomyopathy
4. Hemodynamic implications of left bundle branch block
5. Acute effects of intraoperative multisite ventricular pacing on left ventricular function and activation/contraction sequence in patients with depressed ventricular function
6. Ventricular contraction abnormalities in dilated cardiomyopathy: Effect of biventricular pacing to correct interventricular dyssynchrony
7. Natural history of abnormal conduction and its relation to prognosis in patients with dilated cardiomyopathy
8. Factors influencing the one-year mortality of dilated cardiomyopathy
9. Intraventricular conduction delay: A prognostic marker in chronic heart failure
10. Long-term prognosis of patients presenting to the emergency room with decompensated congestive heart failure
11. Acute hemodynamic effects of biventricular DDD pacing in patients with end-stage heart failure
12. Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay
13. Effect of facing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure
14. Multisite pacing as a supplemental treatment of congestive heart failure: Preliminary results of the Medtronic Inc. InSync Study
15. A pilot experience with permanent biventricular pacing to treat advanced heart failure
16. Evaluation of left ventricular function and mitral regurgitation during left ventricular-based pacing in patients with heart failure
17. Reversal of left ventricular remodeling by synchronous biventricular pacing in heart failure
18. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay
19. Reduction of hospital days by biventricular pacing
20. Rationale and design of a randomized clinical trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with advanced heart failure: The Multicenter InSync Randomized Clinical Evaluation (MIRACLE)
21. The 6-minute walk: A new measure of exercise capacity in patients with chronic heart failure
22. Methods of exercise testing
23. Patients' self-assessment of their congestive heart failure. II. Content, reliability, and validity of a new measure - The Minnesota Living with Heart Failure Questionnaire
24. Permanent left ventricular pacing with transvenous leads inserted into the coronary veins
25. Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure
26. Nonparametric estimation from incomplete observations
27. Contributions to the theory of rank order statistics - The two-sample case
28. Regression models and life-tables
29. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors
30. Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure
31. Absence of effect on exercise capacity of 12-weeks treatment with ramipril in patients with moderate congestive heart failure
32. Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure: The PRECISE Trial
33. Adverse events with transvenous left ventricular pacing in patients with severe heart failure: Early experience from a single centre
34. Effects of vesnarinone on morbidity and mortality in patients with heart failure
35. A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure
36. Randomized trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
37. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: Randomised trial - The Losartan Heart Failure Survival Study ELITE II
38. Heart failure management using implantable devices for ventricular resynchronization: Comparison of Medical Therapy, Pacing, and Defibrillation in Chronic Heart Failure (COMPANION) trial
39. The CARE-HF study (CArdiac REsynchronisation in Heart Failure study): Rationale, design and end-points